Affiliation:
1. Departments of Endocrinology and Metabolism, Sher-i-Kashmir Institute of Medical Sciences,
Srinagar, Jammu and Kashmir, India | Department of Clinical Research, Sher-i-Kashmir Institute of Medical Sciences,
Srinagar, Jammu and Kashmir, India
Abstract
Background:
Polycystic ovary syndrome (PCOS) is a long-term, highly prevalent, complex heterogeneous, polygenic endocrine disorder characterized by both metabolic and reproductive disorders. It affects 6-23% of reproductive age women globally
Objective:
This review aims to facilitate an understanding of novel PCOS management approaches and highlights the results from relevant interventional studies from animal and human studies.
Methods:
Manual search on PubMed, Cochrane, Scopus databases was performed for relevant articles, preclinical and clinical trials based on related keywords.
Results:
According to a multitude of studies, PCOS has evolved over time, but a substantial lag remains in management approaches. New insights into the cross-talk between muscle, brain, fat, and ovaries pointed out new therapeutic targets. This review has highlighted the efficacy of a wide spectrum of novel therapeutic agents [Phosphodiesterase-4 Inhibitors, Glucagon-like peptide-1 receptor agonists, nutritional supplements (Vitamins D and K, omega-3, prebiotics, probiotics and synbiotics), fecal microbiota transplantation (FMT) and intestinal cytokine IL-22] as PCOS therapeutic options. These novel therapies combine anti-inflammatory, insulin sensitizing, anti-obesity, and restoration of the gut microbiota and thus hold the potential to address the basic pathogenic mechanisms of PCOS.
Conclusion:
Exhaustive, multicentric and multiethnic studies are vital to generate a network of normative data to better figure out the PCOS trajectory and change prognostic outcomes. Preclinical and clinical data is warranted to corroborate the new therapeutics and direct health care resources accordingly.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Pharmacology
Reference67 articles.
1. Bulsara J.P.; Patel P.; Soni A.; Acharya S.; A review on brief insight into polycystic ovarian syndrome. Endocrine Metab Sci 2021,3,100085
2. Deswal R.; Narwal V.; Dang A.; Pundir C.S.; The prevalence of polycystic ovary syndrome: a brief systematic review. J Hum Reprod Sci 2020,13(4),261-271
3. Costello M.; Garad R.; Hart R.; A review of first line infertility treatments and supporting evidence in women with polycystic ovary syndrome. Med Sci (Basel) 2019,7(9),95
4. White D.M.; Polson D.W.; Kiddy D.; Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. J Clin Endocrinol Metab 1996,81(11),3821-3824
5. Palomba S.; Falbo A.; Zullo F.; Orio F.; Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a com-prehensive review. Endocr Rev 2009,30(1),1-50
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献